These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23950870)
1. Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes. Stefanska B; Bouzelmat A; Huang J; Suderman M; Hallett M; Han ZG; Al-Mahtab M; Akbar SM; Khan WA; Raqib R; Szyf M PLoS One; 2013; 8(8):e68439. PubMed ID: 23950870 [TBL] [Abstract][Full Text] [Related]
2. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA. Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765 [TBL] [Abstract][Full Text] [Related]
3. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B. Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396 [TBL] [Abstract][Full Text] [Related]
5. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma. Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438 [No Abstract] [Full Text] [Related]
6. Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus. Chen LM; Xiang L; Sun WJ; Zhai YJ; Gao S; Fan YC; Wang K Tohoku J Exp Med; 2020 Dec; 252(4):297-307. PubMed ID: 33239483 [TBL] [Abstract][Full Text] [Related]
7. Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinoma. Chen MM; Zhao RC; Chen KF; Huang Y; Liu ZJ; Wei YG; Jian Y; Sun AM; Qin L; Li B; Qin Y Neoplasma; 2020 Jul; 67(4):909-915. PubMed ID: 32386482 [TBL] [Abstract][Full Text] [Related]
8. Methylation-sensitive high-resolution melting analysis of the USP44 promoter can detect early-stage hepatocellular carcinoma in blood samples. Kim SC; Kim J; Kim DW; Choi Y; Park K; Cho EJ; Yu SJ; Kim-Ha J; Kim YJ BMB Rep; 2022 Nov; 55(11):553-558. PubMed ID: 36016503 [TBL] [Abstract][Full Text] [Related]
9. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma. Ji XF; Fan YC; Gao S; Yang Y; Zhang JJ; Wang K World J Gastroenterol; 2014 Apr; 20(16):4723-9. PubMed ID: 24782625 [TBL] [Abstract][Full Text] [Related]
10. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma. Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717 [TBL] [Abstract][Full Text] [Related]
11. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma. Jain S; Chen S; Chang KC; Lin YJ; Hu CT; Boldbaatar B; Hamilton JP; Lin SY; Chang TT; Chen SH; Song W; Meltzer SJ; Block TM; Su YH PLoS One; 2012; 7(4):e35789. PubMed ID: 22536438 [TBL] [Abstract][Full Text] [Related]
12. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma. Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364 [TBL] [Abstract][Full Text] [Related]
14. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma. Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384 [TBL] [Abstract][Full Text] [Related]
15. Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets. Stefanska B; Cheishvili D; Suderman M; Arakelian A; Huang J; Hallett M; Han ZG; Al-Mahtab M; Akbar SM; Khan WA; Raqib R; Tanvir I; Khan HA; Rabbani SA; Szyf M Clin Cancer Res; 2014 Jun; 20(12):3118-32. PubMed ID: 24763612 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357 [TBL] [Abstract][Full Text] [Related]
17. Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinoma. Xie GF; Xu YX; Xu F; Sun LY; Ye ZL; Ma JJ; Wang HY; Shao JY Neoplasma; 2021 Jan; 68(1):62-70. PubMed ID: 33118832 [TBL] [Abstract][Full Text] [Related]
18. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction. Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma. Bai Y; Tong W; Xie F; Zhu L; Wu H; Shi R; Wang L; Yang L; Liu Z; Miao F; Zhao Q; Zhang Y Aging (Albany NY); 2021 Jul; 13(13):17592-17606. PubMed ID: 34237708 [TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers. Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]